A bariatric surgeon compares GLP-1 agonists and how your doctor will decide which one is the best fit for you
Value of both clinical trials and real-world data studies Both the SURMOUNT-5 clinical trial and Truveta Researchs real-world evidence study reinforce the same key trend: tirzepatide-based medications consistently outperform semaglutide-based medications for weight loss in patients with overweight or obesity
Common reported side-effects: Pain or redness at the injection site Rare swelling at the injection site Rarely reported side effects include: Dizziness Flushing Headaches Sleepiness Hyperactivity Re-test date for IGF-1 in 3 mos to ensure proper growth hormone levels after treatment If you have any questions or concerns, please call our office
Multi-strain diversity Because your needs span two categories, SCFA support and digestive comfort, a formula that includes both Lactobacillus and Bifidobacterium species, plus hardy spore-forming Bacillus strains, gives you broader coverage than any single strain
In clinical trials, participants lost between 12 and 26 pounds on average
Some experts point out that regular injections should only be used as a last resort if supplements dont work or if deficiency symptoms are serious.